American Journal of Obstetrics & Gynecology
Volume 194, Issue 2 , Pages 408-414 , February 2006

Targeted prenatal herpes simplex virus testing: Can we identify women at risk of transmission to the neonate?

  • Karen E. Mark, MD, MPH

      Affiliations

    • Departments of Medicine
    • Epidemiology
    • Corresponding Author InformationReprint requests: Karen E. Mark, MD, MPH, University of Washington Virology Research Clinic, 600 Broadway, Suite 400, Seattle, WA 98122.
    • ,
  • H. Nina Kim, MD, MS

      Affiliations

    • Departments of Medicine
    • Epidemiology
    • ,
  • Anna Wald, MD, MPH

      Affiliations

    • Departments of Medicine
    • Epidemiology
    • Fred Hutchinson Cancer Research Center, Seattle, WA
    • ,
  • Carolyn Gardella, MD, MPH

      Affiliations

    • Obstetrics and Gynecology, University of Washington
    • ,
  • Susan D. Reed, MD, MPH

      Affiliations

    • Epidemiology
    • Obstetrics and Gynecology, University of Washington
    • Fred Hutchinson Cancer Research Center, Seattle, WA

Received 6 April 2005 ,Revised 7 July 2005 ,Accepted 8 August 2005.

References 

  1. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17:1–13
  2. Marques AR, Straus SE. Herpes simplex type 2 infections—an update. Adv Intern Med. 2000;45:175–208
  3. ACOG practice bulletin: Management of herpes in pregnancy. Internat J Gynecol Obstet. 2000;68:165–173
  4. Whitley R, Nahmias A, Visintine A, Fleming C, Alford C. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980;66:489–494
  5. Yeager A, Arvin A. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics. 1984;73:188–193
  6. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203–209
  7. Brown ZA. HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol. 2000;10:141–144
  8. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350:11–20
  9. Centers for Disease Control and Prevention . Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 2002;51:1–78
  10. Baker D, Brown Z, Hollier LM, Wendel GD, Hulme L, Griffiths DA, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol. 2004;191:2074–2084
  11. Wilkinson D, Barton S, Cowan F. HSV-2 specific serology should not be offered routinely to antenatal patients. Rev Med Virol. 2000;10:145–153
  12. Guerry SL, Bauer HM, Klausner JD, Branagan B, Kerndt PR, Allen BG, et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis. 2005;40:38–45
  13. Kotelchuck M. The Adequacy of Prenatal Care Utilization Index: its US distribution and association with low birthweight. Am J Public Health. 1994;84:1486–1489
  14. Johnson EB, Reed SD, Hitti J, Batra M. Increased risk of adverse pregnancy outcome among Somali immigrants in Washington state. Am J Obstet Gynecol. 2005;193:475–482
  15. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont (CA): Lifetime Learning Publications; 1982;p. 340-63
  16. Bergeron MG, Ke D, Menard C, Picard FJ, Gagnon M, Bernier M, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med. 2000;343:175–179
  17. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509–516
  18. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol. 1971;110:825–837
  19. Sawtell NM, Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol. 1992;66:2150–2156
  20. Gutierrez KM, Falkovitz Halpern MS, Maldonado Y, Arvin AM. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis. 1999;180:199–202
  21. Fonnest G, de la Fuente Fonnest I, Weber T. Neonatal herpes in Denmark 1977-1991. Acta Obstet Gynecol Scand. 1997;76:355–358
  22. Garland SM. Neonatal herpes simplex: Royal Women's Hospital 10-year experience with management guidelines for herpes in pregnancy. Aust N Z J Obstet Gynaecol. 1992;32:331–334
  23. Sullivan-Bolyai JZ, Hull HF, Wilson C, Smith AL, Corey L. Presentation of neonatal herpes simplex virus infections: implications for a change in therapeutic strategy. Pediatr Infect Dis. 1986;5:309–314
  24. Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001;285:3100–3106
  25. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol. 2003;102:1396–1403
  26. Mindel A, Taylor J, Tideman RL, Seifert C, Berry G, Wagner K, et al. Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect. 2000;76:287–291
  27. Barnabas RV, Carabin H, Garnett GP. The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis. Sex Transm Infect. 2002;78:425–429

 Partially supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants P01 A137031, T32 AI07044, and T32 AI007140.

PII: S0002-9378(05)01260-3

doi: 10.1016/j.ajog.2005.08.018

American Journal of Obstetrics & Gynecology
Volume 194, Issue 2 , Pages 408-414 , February 2006

Article Tools